In Toronto on September 12, 2025, Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical firm specializing in plant-derived cannabinoid-based products, has appointed Nick Hilborn, CPA, CA, as the Interim Chief Financial Officer. This announcement follows the transition of Phillip Cardella, CPA, CA, to a consultant role effective Monday, September 15, 2025.